Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Selective Estrogen Receptor Modulators
100%
Tamoxifen Metabolites
100%
UDP-glucuronosyltransferase
100%
In Cancer
100%
Deactivation
100%
Adverse Events
100%
Tamoxifen Therapy
100%
Inter-individual Variability
100%
Breast Cancer Patients
100%
Cancer Prevention
100%
Resistance Development
100%
Pharmacogenetics
100%
Cancer Treatment
100%
Recurrent Disease
100%
Deep Vein Thrombosis
100%
Hot Flashes
100%
Metabolic Enzymes
100%
Patient Response
100%
Breast Cancer Mortality
100%
Endometrial Cancer
100%
ER+ Breast Cancer
100%
Contralateral Breast Cancer
100%
Prevention Focus
100%
Medicine and Dentistry
Cancer Prevention
100%
Cancer Therapy
100%
Tamoxifen
100%
Pharmacogenetics
100%
Breast Cancer
33%
Enzymes
22%
Metabolite
11%
Adverse Event
11%
Cancer Mortality
11%
Recurrent Disease
11%
Hot Flush
11%
Deep Vein Thrombosis
11%
Contralateral
11%
Glucuronosyltransferase
11%
Selective Estrogen Receptor Modulator
11%
Estrogen Receptor Positive Breast Cancer
11%
Uterine Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tamoxifen
100%
Pharmacogenetics
100%
Breast Cancer
33%
Enzymes
22%
Glucuronosyltransferase
11%
Adverse Event
11%
Cancer Mortality
11%
Recurrent Disease
11%
Estrogen Receptor Positive Breast Cancer
11%
Deep Vein Thrombosis
11%
Hot Flush
11%
Endometrium Cancer
11%
Selective Estrogen Receptor Modulator
11%
Nursing and Health Professions
Cancer Therapy
100%
Tamoxifen
100%
Cancer Prevention
100%
Breast Cancer
33%
Economic and Social Development
22%
Enzyme
22%
Adverse Event
11%
Deep Vein Thrombosis
11%
Hot Flush
11%
Cancer Mortality
11%
Recurrent Disease
11%
Endometrium Cancer
11%